JP2018503647A5 - - Google Patents

Download PDF

Info

Publication number
JP2018503647A5
JP2018503647A5 JP2017539234A JP2017539234A JP2018503647A5 JP 2018503647 A5 JP2018503647 A5 JP 2018503647A5 JP 2017539234 A JP2017539234 A JP 2017539234A JP 2017539234 A JP2017539234 A JP 2017539234A JP 2018503647 A5 JP2018503647 A5 JP 2018503647A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
group
substituted
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017539234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018503647A (ja
JP6615896B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/015251 external-priority patent/WO2016123275A1/en
Publication of JP2018503647A publication Critical patent/JP2018503647A/ja
Publication of JP2018503647A5 publication Critical patent/JP2018503647A5/ja
Application granted granted Critical
Publication of JP6615896B2 publication Critical patent/JP6615896B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017539234A 2015-01-30 2016-01-28 アルドステロン合成酵素阻害剤 Active JP6615896B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562109890P 2015-01-30 2015-01-30
US62/109,890 2015-01-30
PCT/US2016/015251 WO2016123275A1 (en) 2015-01-30 2016-01-28 Aldosterone synthase inhibitors

Publications (3)

Publication Number Publication Date
JP2018503647A JP2018503647A (ja) 2018-02-08
JP2018503647A5 true JP2018503647A5 (enExample) 2019-03-07
JP6615896B2 JP6615896B2 (ja) 2019-12-04

Family

ID=55361967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017539234A Active JP6615896B2 (ja) 2015-01-30 2016-01-28 アルドステロン合成酵素阻害剤

Country Status (4)

Country Link
US (1) US10131642B1 (enExample)
EP (1) EP3250569B1 (enExample)
JP (1) JP6615896B2 (enExample)
WO (1) WO2016123275A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7225253B2 (ja) * 2018-02-02 2023-02-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グレリンo-アシルトランスフェラーゼ(goat)阻害剤として使用するためのピラゾール置換及びインダゾール置換オキサジアゾロピリジン誘導体
CA3087925A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
MX2020008053A (es) 2018-02-02 2020-09-07 Boehringer Ingelheim Int Derivados de oxadiazolopiridina sustituidos con bencilo, (piridin-3-il)metilo o (piridin-4-il)metilo como inhibidores de ghrelin o-aciltransferasa (goat).
CN111655699B (zh) * 2018-02-02 2023-07-14 勃林格殷格翰国际有限公司 用作饥饿素o-酰基转移酶(goat)抑制剂的杂环基取代的噁二唑并吡啶衍生物
WO2021233884A1 (en) 2020-05-22 2021-11-25 Boehringer Ingelheim International Gmbh Continuous process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate
EP4153599B1 (en) 2020-05-22 2024-03-13 Boehringer Ingelheim International GmbH Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate
WO2026093586A1 (en) 2024-11-04 2026-05-07 AstraZeneca Ireland Limited Combination of a aldosterone synthase inhibitor (asi) and a sodium-glucose co-transporter 2 inhibitor (sglt2i) for use in methods of reducing the risk of cardiovascular and heart failure events in a subject

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4544864B2 (ja) * 2002-03-08 2010-09-15 独立行政法人科学技術振興機構 イソキサゾール誘導体及びその製造方法
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
BRPI0709678A2 (pt) * 2006-03-29 2011-07-19 Novartis Ag compostos orgánicos
WO2007139992A2 (en) * 2006-05-26 2007-12-06 Novartis Ag ALDOSTERONE SYNTHASE AND/OR 11β-HYDROXYLASE INHIBITORS
ITMI20062102A1 (it) * 2006-11-02 2008-05-03 Abiogen Pharma Spa Nuovui sali di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidrobenzo-d-isossazol-4-one
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Similar Documents

Publication Publication Date Title
JP2021528488A5 (enExample)
JP2019524883A5 (enExample)
JP2011518811A5 (enExample)
JP2008520742A5 (enExample)
JP2017531016A5 (enExample)
JP2016540742A5 (enExample)
JP2018535963A5 (enExample)
JP2011529054A5 (enExample)
JP2018501285A5 (enExample)
JP2016505614A5 (enExample)
JP2014511891A5 (enExample)
JP2005526076A5 (enExample)
JP2004529911A5 (enExample)
JPWO2023195529A5 (enExample)
JP2013530237A5 (enExample)
JP2011513367A5 (enExample)
JP2013542267A5 (enExample)
JP2015504909A5 (enExample)
JP2017522348A5 (enExample)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
JP2010155827A5 (enExample)
JP2015508092A5 (enExample)
JP2019519616A5 (enExample)
JP2012526769A5 (enExample)
JP2015524483A5 (enExample)